| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/14/2008 | US20080193426 Increasing homing of CD34 by administering chemokines, fusion protein; irradiation, cyclophosphamide or 5-fluorouracil; interleukins; Gaucher disease |
| 08/14/2008 | US20080193425 Methods for administering fgf18 |
| 08/14/2008 | US20080193415 HSA-free formulations of interferon-beta |
| 08/14/2008 | US20080193414 Use of an Immunoglobulin Domain-Containing Cell Surface Recognition Molecule For Treating Diseases |
| 08/14/2008 | US20080193413 Anti-Infective Agents |
| 08/14/2008 | US20080193412 Method of Enhancing the Immune Response to a Vaccine |
| 08/14/2008 | US20080193411 Anti-viral Compounds |
| 08/14/2008 | US20080193410 Treating warts or verrucae that are induced by papillomavirus; killed mumps virus, candida or trichophyton extract; cytokines or colony stimulating factor |
| 08/14/2008 | US20080193409 Compositions and Methods for Therapy or Prevention of Chemotherapy-Induced Neuropathy |
| 08/14/2008 | US20080193403 Inducing And Maintaining Hair Color |
| 08/14/2008 | US20080193389 Use of glycodendrimer reagents for inhibiting adhesion by microorganisms |
| 08/14/2008 | US20080193375 Lung cancer-targeted peptides and applications thereof |
| 08/14/2008 | CA2715042A1 Multivariable antigens complexed with targeting humanized monoclonal antibody |
| 08/14/2008 | CA2685437A1 Compositions and methods including expression and bioactivity of bovine follicle stimulating hormone |
| 08/14/2008 | CA2677803A1 Compositions and methods to prevent cancer with cupredoxins |
| 08/14/2008 | CA2677665A1 Methods and compositions related to inhibition of viral entry |
| 08/14/2008 | CA2677233A1 Prophylactic agent for autoimmune disease |
| 08/14/2008 | CA2677228A1 Use of semaphorin 6a for promoting myelination and oligodendrocyte differentiation |
| 08/14/2008 | CA2677160A1 Variants derived from actriib and uses therefor |
| 08/13/2008 | EP1956374A1 Detection and treatment of cancer |
| 08/13/2008 | EP1956093A1 von Willebrand Factor (vWF)-cleaving protease |
| 08/13/2008 | EP1956082A1 Reversibly inactivated acidified plasmin |
| 08/13/2008 | EP1956079A1 Neural progenitor cells |
| 08/13/2008 | EP1956030A1 Secreted and transmembrane polypeptides and nucleic acids endoding the same |
| 08/13/2008 | EP1955715A1 Use of Sirt7 for treating age-related diseases |
| 08/13/2008 | EP1955714A1 Detection and treatment of cancer |
| 08/13/2008 | EP1955708A1 Novel memory ctl induction potentiator |
| 08/13/2008 | EP1955706A1 Interferon-alpha and c-phycocyanin for the treatment of autoimmune diseases, allergic diseases and cancer |
| 08/13/2008 | EP1955705A1 Wound healing agent and composition |
| 08/13/2008 | EP1955704A1 Wound healing agent and composition |
| 08/13/2008 | EP1955703A1 Viruses for the treatment of cellular proliferative disorders |
| 08/13/2008 | EP1955698A1 Preventive/therapeutic agent for alzheimer's dementia |
| 08/13/2008 | EP1955602A1 Milk fractions and milk preparations for treating and/or preventing COX-2 mediated diseases |
| 08/13/2008 | EP1954719A2 Compositions and methods for the treatment of diseases and disorders associated with cytokine signaling involving antibodies that bind to il-22 and il-22r |
| 08/13/2008 | EP1954718A2 Anti-a globulomer antibodies, antigen-binding moieties thereof, corresponding hybridomas, nucleic acids, vectors, host cells, methods of producing said antibodies, compositions comprising said antibodies, uses of said antibodies and methods of using said antibodies |
| 08/13/2008 | EP1954717A2 Peptide inhibitors of abl kinases |
| 08/13/2008 | EP1954714A2 Hepatocyte growth factor intron fusion proteins |
| 08/13/2008 | EP1954318A1 Siglec-9 binding agents |
| 08/13/2008 | EP1954313A1 Treatment of obesity and related disorders |
| 08/13/2008 | EP1954310A2 Method of using il6 antagonists with proteasome inhibitors |
| 08/13/2008 | EP1954304A2 Compositions and methods for prolonging survival of platelets |
| 08/13/2008 | EP1954303A2 Improved reproductive management |
| 08/13/2008 | EP1954302A2 Biosynthetic polypeptide fusion inhibitors |
| 08/13/2008 | EP1954286A2 Inhibitors of akt activity |
| 08/13/2008 | EP1954242A1 Orally absorbed pharmaceutical formulation and method of administration |
| 08/13/2008 | EP1898692A4 Alternate morpheeins of allosteric proteins as a target for the development of bioactive molecules |
| 08/13/2008 | EP1678196B1 Sulfonylamino-peptidomimetics active on the somatostatin receptor subtypes 4 (sstr4) and 1 (sstr1) |
| 08/13/2008 | EP1664093B8 Antitumoral compounds based on Kahalalide F |
| 08/13/2008 | EP1610765B1 Non-aqueous single phase vehicles and formulations utilizing such vehicles |
| 08/13/2008 | EP1589949B1 Stabilized lyophilized compositions comprising tissue factor pathway inhibitor or tissue factor pathway inhibitor variants |
| 08/13/2008 | EP1565183B1 Rapamycin and il-10 for the treatment of autoimmune diseases |
| 08/13/2008 | EP1483290B1 Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments |
| 08/13/2008 | EP1463801B1 Transdifferentiation of pancreatic acinar cells |
| 08/13/2008 | EP1453501B1 N- aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity |
| 08/13/2008 | EP1421946B1 A pharmaceutical composition for treating hiv infection |
| 08/13/2008 | EP1359931A4 Prevention of diabetes by administration of gnrh antagonists |
| 08/13/2008 | EP1274453B1 Recombinant bcg vaccines against intracellular pathogens and methods for use |
| 08/13/2008 | EP1272636B1 A gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 08/13/2008 | EP1244704B1 Methods of inhibiting the binding of a cd8+ t cell to a class i mhc employing a modified beta 2 microglobulin |
| 08/13/2008 | EP1214453B1 Novel cell cycle checkpoint genes and proteins encoded thereby |
| 08/13/2008 | EP1213028B1 Hm1.24 antigen expression potentiators |
| 08/13/2008 | EP1200117B1 Lipoprotein lipase (lpl) variant therapeutics |
| 08/13/2008 | EP1154759B1 Dispersible concentrate for the delivery of cyclosporin |
| 08/13/2008 | EP1137773B1 Growth factor homolog zvegf3 |
| 08/13/2008 | EP1133519B1 Functional antagonists of hedgehog activity |
| 08/13/2008 | EP1064308B1 Methods for identifying inducers and inhibitors of proteolytic antibodies, compositions and their uses |
| 08/13/2008 | EP0894140B1 Allele suppression |
| 08/13/2008 | EP0827537B1 Chromatin-regulator genes |
| 08/13/2008 | EP0669987B1 Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system, particularly in brain |
| 08/13/2008 | CN101243193A Polymorphism in cysteine dioxygenase |
| 08/13/2008 | CN101242857A PEG-IFNa and ribavirin for HBV treatment |
| 08/13/2008 | CN101242853A Amylases for pharmaceutical use |
| 08/13/2008 | CN101242852A Methods of protecting against apoptosis using lipopeptides |
| 08/13/2008 | CN101242851A Method of use of antagonists of zonulin to prevent the loss of or to regenerate pancreatic cells |
| 08/13/2008 | CN101242812A Pancreatin micropellets suitable for enteric coating |
| 08/13/2008 | CN101242811A Controlled release pharmaceutical compositions for acid labile drugs |
| 08/13/2008 | CN101242748A Infant nutrition with protease inhibitor |
| 08/13/2008 | CN101241127A Sgk and Nedd used as diagnostic and therapeutic targets |
| 08/13/2008 | CN101240033A Fusion protein of insulin secretion accelerating peptide and human serum albumin, and preparation method thereof |
| 08/13/2008 | CN101240032A Broad spectrum influenza virus resistant antagonistic peptide nasal spray preparation and application |
| 08/13/2008 | CN101240031A Conjugate constructed from normal heptadecyl and RGD peptide, and its preparation method and application |
| 08/13/2008 | CN101240030A Conjugate constructed from normal undecyl and RGD peptide, and its synthesis and application in medicine |
| 08/13/2008 | CN101240029A Conjugate constructed from normal heptyl and RGD peptide, and its synthesis method and application |
| 08/13/2008 | CN101240028A Conjugate constructed from normal pentadecyl and RGD peptide, and its synthesis and application in medicine |
| 08/13/2008 | CN101240027A Conjugate constructed from normal nonyl and RGD peptide, and its synthesis and application in medicine |
| 08/13/2008 | CN101240026A Conjugate constructed from normal tridecyl and RGD peptide, and its synthesis and application in medicine |
| 08/13/2008 | CN101240020A Breast cancer biological molecule marker LASS2 protein, modifying product and medical composition thereof |
| 08/13/2008 | CN101240018A Peptides and related compounds having thrombopoietic activity |
| 08/13/2008 | CN101240017A A uro-genital disease treatment system |
| 08/13/2008 | CN101240015A Core-peptide composition with physiological activity and its preparation method and application |
| 08/13/2008 | CN101240014A Lipopeptid composition with physiological activity and its preparation method and application |
| 08/13/2008 | CN101239186A Use of soluble lymphotoxin-beta receptors |
| 08/13/2008 | CN101239185A Preventive or therapeutic agent for inflammatory bowel disease comprising IL-6 antagonist as an active ingredient |
| 08/13/2008 | CN101239184A Application of human glutathione-S-transferase pi in preparing medicaments for treating whole body inflammation |
| 08/13/2008 | CN101239183A Application of Septin1 protein in preparing medicaments for treating lymphocyte leukemia |
| 08/13/2008 | CN101239182A Calcium phosphate delivery vehicles for osteoinductive proteins |
| 08/13/2008 | CN101239181A Histone demethylase related to cancer and uses thereof |
| 08/13/2008 | CN101239180A Complexes for target killing tumor cell, preparation and application thereof |
| 08/13/2008 | CN101239179A Non-aqueous polar aprotic peptide formulations |
| 08/13/2008 | CN101239178A Antithrombotic use of peptide compounds |